GlassScriptPhysician profile
David Kallenberger
NPI 1427001668
$2,935.79
in general payments reported to CMS, 2019-2025
26 companies · $76.05 in 2025
The $76.05 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $538 · 2020: $339 · 2021: $838 · 2022: $896 · 2023: $161 · 2024: $87.37 · 2025: $76.05.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $325.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $324.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $652.90 | 2019-2023 | |
| Gynesonics, INC. | $333.93 | 2022 | |
| Merck Sharp & Dohme LLC | $315.99 | 2019-2021 | |
| Organon LLC | $202.93 | 2021-2023 | Follistim Aq, Pregnyl, Ganirelix Acetate |
| Sage Therapeutics, LLC | $134.53 | 2021-2025 | Zurzuvae |
| Ferring Pharmaceuticals INC. | $130.34 | 2019-2025 | Menopur |
| Mayne Pharma Commercial LLC | $129.63 | 2021-2023 | |
| Coopersurgical, INC. | $129.19 | 2020-2021 | |
| Therapeuticsmd, INC. | $123.97 | 2019-2021 | |
| Pfizer INC. | $114.17 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $112.49 | 2019-2022 | |
| Myovant Sciences INC. | $110.36 | 2021-2022 | |
| Emd Serono, INC. | $98.15 | 2019-2022 | |
| Astellas Pharma US INC | $76.22 | 2023-2024 | Veozah |
| Baxter Healthcare | $48.32 | 2020-2021 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Roche Diagnostics Corporation | $29.19 | 2020-2021 | |
| Sumitomo Pharma America, INC. | $26.93 | 2023 | Myfembree |
| Ultragenyx Pharmaceutical INC. | $23.44 | 2021 | |
| Mission Pharmacal Company | $22.80 | 2019 | |
| Axonics, INC. | $22.27 | 2023 | Bulkamid |
| Hologic Sales and Service, LLC | $20.59 | 2025 | Thinprep 2000 Processor, Aptima |
| Avanos Medical | $19.32 | 2020 | |
| Galen US INC | $18.06 | 2019 | |
| Medtronic, INC. | $13.83 | 2022 | |
| Avion Pharmaceuticals | $13.51 | 2022 | |
| Acessa Health INC. | $12.73 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Kallenberger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.